SGN-CD19B, a Pyrrolobenzodiazepine (PBD)-Based Anti-CD19 Drug Conjugate, Demonstrates Potent Preclinical Activity Against B-Cell Malignancies

Autor: Ryan, Maureen C. *, Schimpf, Brian *, Anderson, Martha *, Zeng, Weiping *, Emmerton, Kim *, Miyamoto, Jamie *, Kostner, Heather *, Yu, Changpu *, Van Epps, Heather *, Tatalick, Laurie *, Benjamin, Dennis *
Zdroj: In Blood 3 December 2015 126(23):594-594
Databáze: ScienceDirect